Unresectable metastatic liver disease: new therapeutical alternatives.
Lygidakis
N J
NJ
Athens Medical Center, Apollonion Hospital, Greece. igsc@compulink.gr
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D007269:Injections, Intra-Arterial; D007376:Interleukin-2 / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology / Q000556:secondary; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D008875:Middle Aged; D015996:Survival Rate; D014057:Tomography, X-Ray Computed
D007376:Interleukin-2